Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-136266
Filing Date
2020-05-07
Accepted
2020-05-07 16:16:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d924294ds3.htm S-3 364344
2 EX-4.3 d924294dex43.htm EX-4.3 288847
3 EX-4.4 d924294dex44.htm EX-4.4 98457
4 EX-4.5 d924294dex45.htm EX-4.5 97513
5 EX-4.6 d924294dex46.htm EX-4.6 83137
6 EX-5.1 d924294dex51.htm EX-5.1 27182
7 EX-23.1 d924294dex231.htm EX-23.1 2236
8 GRAPHIC g924294002.jpg GRAPHIC 2947
9 GRAPHIC g924294arcalogo.jpg GRAPHIC 3400
  Complete submission text file 0001193125-20-136266.txt   971928
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238067 | Film No.: 20856640
SIC: 2835 In Vitro & In Vivo Diagnostic Substances